Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences by T. G. Vaykhanskaya, L. N. Sivitskaya, O. D. Levdansky, T. V. Kurushko, N. G. Danilenko

“…To assess clinical outcomes, the NCM group was divided into 2 subtypes according to baseline LV systolic function (NCM/DCM phenotype — 50 individuals with LVEF ≤49%; and isolated NCM — 24 patients with LVEF ≥50%). …”
Get full text

Genetic deletion of the sodium phosphate cotransporter NaPi2a ameliorates heart failure in mice by Hiroko Yamauchi-Sawada, Tomoharu Ida, Masashi Nakamura, Minato Umehara, Natsuko Okuno-Ozeki, Itaru Nakamura, Yayoi Matoba, Atsushi Minamida, Yasuto Sunahara, Tomohiro Nakata, Kunihiro Nakai, Aya Yagi-Tomita, Noriko Uehara-Watanabe, Noriyuki Yamashita, Yuhei Kirita, Keiichi Tamagaki, Benjamin D. Humphreys, Satoaki Matoba, Tetsuro Kusaba

“…Sodium-phosphate co-transporter 2a (NaPi2a) is predominantly expressed in the apical membrane of proximal tubular epithelia and functions to reabsorb filtered phosphate and sodium. …”
Get full text

Cardiac MRI of differing ischemia and reperfusion times in a myocardial infarction pig model by David Boll, Simon Reiss, Heidi R. Cristina Schmitz, Christian Weber, Julien Thielmann, Felix Spreter, Kian Tadjalli Mehr, Diana Chiang, Markus Jäckel, Lukas Heger, Jonathan Rilinger, Dirk Westermann, Constantin von zur Mühlen, Timo Heidt, Michael Bock, Alexander Maier

“…CMR was performed at a clinical 3 T system including functional imaging, T1 and T2 mapping and late gadolinium enhancement (LGE) 2–5 h or three days post-reperfusion. …”
Get full text

Role of the individual metabolic syndrome components and heart remodelling progression in women by E. M. Khurs, A. N. Dmitriev, A. V. Poddubnaya, E. M. Futerman

“…To analyze the dynamics of heart structure, geometry, and function in women, in accordance with present components of metabolic syndrome (MS). …”
Get full text

Severity of obstructive sleep apnea and its impact on coronary artery disease outcomes: A cross-sectional study in Egypt by Hossam Eldin M. Mahmoud, Ahmed Hussein, Esraa A. Taha, Eptehal M. Dongol, Ahmed G. Bakry

“…Conclusion: OSA is prevalent in CAD patients and correlates with worsened cardiac function and increased CAD severity. STOP-BANG score is a useful screening tool. …”
Get full text

Prevalence and Factors Associated with Excess Weight in Patients with Heart Failure in Cali, Colombia by Jhonatan Betancourt-Peña, Julieth Paola Suárez-Hernández, Guillermo Perlaza-Peláez, William Eduardo Escobar-Rodríguez, Adriana Orejuela-Upegui, Mauricio Hernández-Carrillo

“…The study included sociodemographic and clinical variables, functional aerobic capacity measured by the 6-minute walk test, quality of life assessed using the Minnesota Living with Heart Failure Questionnaire (MLFHQ), and depression evaluated by the Patient Health Questionnaire-9 (PHQ-9). …”
Get full text

Cardiac protein changes in rats after soybean oil treatment: a proteomic study by Taisla Soprani, Vinicius Kuffer Uliana, Eduardo Hertel Ribeiro, Sergio Lisboa, Gabriella Xavier Maretto, André Teixeira Silva da Ferreira, Jonas Perales, Ivanita Stefanon, Suely Gomes de Figueiredo

“…Results Soybean oil treatment improved left ventricular function, TR animals presented lower value of LVEDP and significantly changed LV proteome. …”
Get full text

Possibilities of hyperuricemia correction in acute decompensation of heart failure by Laura H. Sarieva, Svetlana N. Nasonova, Marina D. Muksinova, Igor V. Zhirov, Sergey N. Tereshchenko

“…The results of standard therapy of HF with diuretic therapy in combination with xanthine oxidase inhibitor – allopurinol in the starting dose of 50 mg in 36 patients with ADHF of functional class II–IV, hyperuricemia, reduced renal filtration function calculated by the CKD-EPI formula are presented. …”
Get full text

Allopurinol in the complex therapy of acute decompensation of heart failure by Laura H. Sarieva, Marina D. Muksinova, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko

“…Materials and methods. We present the results of a 6-month follow-up for 72 patients with ADHF, hyperuricemia, and reduced filtration function of the kidneys, calculated using the CKD-EPI formula, divided equally into two groups: group 1 received standard of care for HF combined with a xanthine oxidase inhibitor – allopurinol, and group 2 received standard of care only. …”
Get full text

Platypnea-Orthodeoxia Syndrome after Transcatheter Aortic Valve Implantation by Andrew K. Roy, Jerome Garot, Antoinette Neylon, Marco Spaziano, Fadi J. Sawaya, Thierry Lefèvre

“…Progressive dyspnea and hypoxaemia in the subacute phase after transcatheter aortic valve implantation (TAVI) are uncommon and warrant immediate assessment of valve and prosthesis leaflet function to exclude thrombosis, as well as investigation for other causes related to the procedure, such as left ventricular dysfunction, pulmonary embolism, and respiratory sepsis. …”
Get full text

Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction by Marta Wleklik, Christopher S. Lee, Łukasz Lewandowski, Michał Czapla, Maria Jędrzejczyk, Heba Aldossary, Izabella Uchmanowicz

“…Frailty was assessed using Fried phenotype criteria. Cognitive function, depression and nutritional status were evaluated using validated instruments [Mini‐Mental State Examination (MMSE), Patient Health Questionnaire‐9 (PHQ‐9) and Mini Nutritional Assessment (MNA)]. …”
Get full text